Theory Paper IDrNB Cardiology – Theory Notes

TIMI RISK SCORE FOR UNSTABLE ANGINA (UA) AND NSTEMI

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

ICORE CONCEPT AND PURPOSE

  • The Goal: The TIMI (Thrombolysis in Myocardial Infarction) Risk Score is a simple bedside tool used to predict the 14-day risk of all-cause mortality, new or recurrent MI, or severe recurrent ischemia requiring urgent revascularization.
  • Clinical Utility: It helps in the “Paradigm Shift” of deciding which patients benefit from an Early Invasive Strategy (Catheterization within 24 to 48 hours) versus an initial conservative approach.

IITHE TIMI RISK SCORE COMPONENTS

  • Structure: The score is composed of 7 independent variables. Each variable is worth 1 point (Total score range: 0 to 7).
  • Age 65 years or older.
  • At least 3 risk factors for Coronary Artery Disease (CAD): (Family history of CAD, hypertension, hypercholesterolemia, diabetes, or current smoking).
  • Prior Coronary Stenosis of 50 percent or more: (Known from previous angiography).
  • ST-segment deviation of 0.5 mm or more on admission ECG.
  • At least 2 anginal episodes in the last 24 hours.
  • Use of Aspirin in the last 7 days.
  • Elevated serum cardiac biomarkers: (Troponin or CK-MB).

IIIRISK CATEGORIZATION AND PROGNOSIS

  • Gradient of Risk: The 14-day risk of death, MI, or urgent revascularization rises steadily with the score (Antman et al., JAMA 2000):
TIMI Score 14-Day Event Rate Risk Category
0–1 4.7% Low
2 8.3% Low
3 13.2% Intermediate
4 19.9% Intermediate
5 26.2% High
6–7 40.9% High

IVRECOMMENDATIONS FOR MANAGEMENT (ESC 2023 ACS / ACC-AHA 2025 ACS)

  • High Risk (TIMI 5 to 7):
    • Recommendation: Early invasive strategy (within 24 hours), or immediate (within 2 hours) if very-high-risk features are present. These patients derive the greatest absolute benefit from early revascularization.
  • Intermediate Risk (TIMI 3 to 4):
    • Recommendation: Invasive strategy during the index admission. Benefit is significant but less than in the high-risk group.
  • Low Risk (TIMI 0 to 2):
    • Recommendation: Selective invasive approach guided by non-invasive ischemia testing. An invasive strategy may be deferred unless the patient fails medical therapy or shows ischemia on stress tests.

VTHE DISTINCTION DATA: LIMITATIONS AND COMPARISONS

  • The “Aspirin” Factor: Prior Aspirin use is a marker of “higher-risk biology” or plaque that has already “failed” medical therapy, which is why it is an independent risk predictor.
  • TIMI vs. GRACE Score: While the TIMI score is easier to calculate at the bedside, the GRACE (Global Registry of Acute Cardiac Events) Score is considered more accurate for predicting both in-hospital and 6-month mortality.
  • Guideline Position: The 2023 ESC ACS Guidelines recommend considering the GRACE score for prognostic estimation, while TIMI remains a quick bedside triage tool.

VITHE INDIAN CLINICAL CONTEXT

  • The “Early Presenter” Challenge: Many NSTEMI patients present within the “Golden Hour.” In these cases, even a low TIMI score should not delay an ECG and Troponin assessment.
  • The Diabetic Threshold: Since a large proportion of Indian NSTEMI patients are diabetic, clinicians commonly use a lower threshold for an invasive strategy, effectively treating most diabetic NSTEMI cases as “Intermediate to High Risk” regardless of the total TIMI score.
  • Troponin Assay Sensitivity: With the widespread use of High-Sensitivity Troponin (hs-cTn), the “Biomarker” point is triggered more often, shifting more patients into the intermediate-risk category compared to older CK-MB based scoring.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.